210 related articles for article (PubMed ID: 23990184)
1. Vernakalant: Perception of state of health in patients with a recent-onset atrial fibrillation.
Conde D; Costabel JP; Aragon M; Lambardi F; Trivi M
Cardiol J; 2014; 21(3):304-8. PubMed ID: 23990184
[TBL] [Abstract][Full Text] [Related]
2. Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.
Conde D; Costabel JP; Aragon M; Lambardi F; Klein A; Corrales Barbosa A; Trivi M; Giniger A
Cardiovasc Ther; 2013 Dec; 31(6):377-80. PubMed ID: 23683253
[TBL] [Abstract][Full Text] [Related]
3. Conversion of Recent-Onset Atrial Fibrillation: Which Drug is the Best?
Conde D; Elissamburu P; Lalor N; Rodriguez L; Aragon M; Costabel JP; Lambardi F; Trivi M
J Atr Fibrillation; 2013; 6(2):910. PubMed ID: 28496882
[No Abstract] [Full Text] [Related]
4. Flecainide versus vernakalant for conversion of recent-onset atrial fibrillation.
Conde D; Costabel JP; Caro M; Ferro A; Lambardi F; Corrales Barboza A; Lavalle Cobo A; Trivi M
Int J Cardiol; 2013 Oct; 168(3):2423-5. PubMed ID: 23518212
[TBL] [Abstract][Full Text] [Related]
5. Intravenous vernakalant in comparison with intravenous flecainide in the cardioversion of recent-onset atrial fibrillation.
Pohjantähti-Maaroos H; Hyppölä H; Lekkala M; Sinisalo E; Heikkola A; Hartikainen J
Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):114-120. PubMed ID: 28849946
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs.
Balla I; Petrela E; Kondili A
Anadolu Kardiyol Derg; 2011 Nov; 11(7):600-6. PubMed ID: 21911317
[TBL] [Abstract][Full Text] [Related]
7. Is vernakalant better or not, compared with other treatments for conversion of acute atrial fibrillation?
Conde D
Int J Cardiol; 2013 Oct; 169(2):95-6. PubMed ID: 24071384
[TBL] [Abstract][Full Text] [Related]
8. Management of patients with acute atrial fibrillation in the ED.
Conti A; Del Taglia B; Mariannini Y; Pepe G; Vanni S; Grifoni S; Abbate R; Michelucci A; Padeletti L; Gensini GF
Am J Emerg Med; 2010 Oct; 28(8):903-10. PubMed ID: 20825922
[TBL] [Abstract][Full Text] [Related]
9. A multicenter, open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm.
Stiell IG; Roos JS; Kavanagh KM; Dickinson G
Am Heart J; 2010 Jun; 159(6):1095-101. PubMed ID: 20569725
[TBL] [Abstract][Full Text] [Related]
10. Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment.
Alboni P; Botto GL; Boriani G; Russo G; Pacchioni F; Iori M; Pasanisi G; Mancini M; Mariconti B; Capucci A
Heart; 2010 Apr; 96(7):546-9. PubMed ID: 20350992
[TBL] [Abstract][Full Text] [Related]
11. Conversion of recent onset atrial fibrillation: which drug is faster?
Conde D
Am J Emerg Med; 2013 Sep; 31(9):1410-1. PubMed ID: 23796978
[No Abstract] [Full Text] [Related]
12. Vernakalant: conversion of atrial fibrillation in patients with ischemic heart disease.
Torp-Pedersen C; Camm AJ; Butterfield NN; Dickinson G; Beatch GN
Int J Cardiol; 2013 Jun; 166(1):147-51. PubMed ID: 22108512
[TBL] [Abstract][Full Text] [Related]
13. [Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects].
Alboni P; Botto GL; Baldi N
Ital Heart J Suppl; 2005 Jun; 6(6):335-40. PubMed ID: 16013424
[TBL] [Abstract][Full Text] [Related]
14. Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm.
Martínez-Marcos FJ; García-Garmendia JL; Ortega-Carpio A; Fernández-Gómez JM; Santos JM; Camacho C
Am J Cardiol; 2000 Nov; 86(9):950-3. PubMed ID: 11053705
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial.
Beatch GN; Mangal B
BMC Cardiovasc Disord; 2016 May; 16():113. PubMed ID: 27233239
[TBL] [Abstract][Full Text] [Related]
16. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.
Alboni P; Botto GL; Baldi N; Luzi M; Russo V; Gianfranchi L; Marchi P; Calzolari M; Solano A; Baroffio R; Gaggioli G
N Engl J Med; 2004 Dec; 351(23):2384-91. PubMed ID: 15575054
[TBL] [Abstract][Full Text] [Related]
17. Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols.
Boriani G; Biffi M; Capucci A; Botto G; Broffoni T; Ongari M; Trisolino G; Rubino I; Sanguinetti M; Branzi A; Magnani B
Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2470-4. PubMed ID: 9825369
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines.
Savelieva I; Graydon R; Camm AJ
Europace; 2014 Feb; 16(2):162-73. PubMed ID: 24108230
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of verapamil, flecainide and propafenone for the acute conversion of atrial fibrillation to sinus rhythm.
Kondili A; Kastrati A; Popa Y
Wien Klin Wochenschr; 1990 Sep; 102(17):510-3. PubMed ID: 2124756
[TBL] [Abstract][Full Text] [Related]
20. Vernakalant in the management of atrial fibrillation.
Cheng JW
Ann Pharmacother; 2008 Apr; 42(4):533-42. PubMed ID: 18334607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
